{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:59:34Z","timestamp":1790794774689,"version":"4.1.0"},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2014,4,30]]},"DOI":"10.18632\/oncotarget.1504","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T23:40:56Z","timestamp":1442360456000},"page":"2052-2064","source":"Crossref","is-referenced-by-count":106,"title":["Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia"],"prefix":"10.18632","volume":"5","author":[{"given":"Valentina","family":"Folgiero","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Transfusion Medicine, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca M.","family":"Goffredo","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perla","family":"Filippini","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Transfusion Medicine, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Masetti","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, S. Orsola-Malpighi Hospital, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Bonanno","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Catholic University Med. School, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Caruso","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Transfusion Medicine, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bertaina","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Transfusion Medicine, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Mastronuzzi","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Transfusion Medicine, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Gaspari","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Transfusion Medicine, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zecca","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni F.","family":"Torelli","sequence":"additional","affiliation":[{"name":"Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Testi","sequence":"additional","affiliation":[{"name":"Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pession","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, S. Orsola-Malpighi Hospital, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Transfusion Medicine, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"},{"name":"University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Rutella","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology and Transfusion Medicine, IRCCS Bambino Ges\u00f9 Children's Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2013,10,30]]},"reference":[{"issue":"16","key":"1","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1182\/blood-2012-03-362608","article-title":"Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel","volume":"120","author":"Raimondi","year":"2012","journal-title":"Blood"},{"issue":"5","key":"2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1200\/JCO.2012.43.7384","article-title":"Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group","volume":"31","author":"Rizzari","year":"2013","journal-title":"J Clin Oncol"},{"issue":"3","key":"3","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1200\/JCO.2011.41.1116","article-title":"Donor lymphocyte infusion induces polyspecific CD8+ T-cell responses with concurrent molecular remission in acute myeloid leukemia with NPM1 mutation","volume":"31","author":"Greiner","year":"2013","journal-title":"J Clin Oncol"},{"issue":"31","key":"4","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1200\/JCO.2007.11.6053","article-title":"Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party","volume":"25","author":"Rocha","year":"2007","journal-title":"J Clin Oncol"},{"issue":"5","key":"5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Weinberg","year":"2011","journal-title":"Cell"},{"issue":"7","key":"6","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1182\/blood-2006-07-036863","article-title":"Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells","volume":"109","author":"Lemoli","year":"2007","journal-title":"Blood"},{"issue":"15","key":"7","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1158\/0008-5472.CAN-11-0108","article-title":"PD-1\/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation","volume":"71","author":"Dolstra","year":"2011","journal-title":"Cancer Res"},{"issue":"5","key":"8","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1172\/JCI63980","article-title":"CD40 ligation reverses T cell tolerance in acute myeloid leukemia","volume":"123","author":"Kline","year":"2013","journal-title":"J Clin Invest"},{"issue":"10","key":"9","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1182\/blood.V97.10.3138","article-title":"Targeting of a B7-1 (CD80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells","volume":"97","author":"Thiel","year":"2001","journal-title":"Blood"},{"issue":"8","key":"10","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1016\/S0021-9258(17)35696-X","article-title":"Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase","volume":"261","author":"Hayaishi","year":"1986","journal-title":"J Biol Chem"},{"issue":"5","key":"11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase","volume":"22","author":"Mellor","year":"2005","journal-title":"Immunity"},{"issue":"5588","key":"12","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1126\/science.1073514","article-title":"Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase","volume":"297","author":"Mellor","year":"2002","journal-title":"Science"},{"issue":"6","key":"13","first-page":"1333","article-title":"Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer","volume":"17","author":"Tanaka","year":"2007","journal-title":"Oncol Rep"},{"issue":"4","key":"14","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1158\/1078-0432.CCR-05-1966","article-title":"Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells","volume":"12","author":"Amberger","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"10","key":"15","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"Van den Eynde","year":"2003","journal-title":"Nat Med"},{"issue":"12","key":"16","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.4161\/cc.8.12.8887","article-title":"IDO recruits Tregs in melanoma","volume":"8","author":"Muller","year":"2009","journal-title":"Cell Cycle"},{"issue":"9","key":"17","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ni.2077","article-title":"Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells","volume":"12","author":"Puccetti","year":"2011","journal-title":"Nat Immunol"},{"issue":"3","key":"18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.leukres.2008.06.014","article-title":"Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-\u03b3","volume":"33","author":"Quesnel","year":"2009","journal-title":"Leuk Res"},{"issue":"1","key":"19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1479-5876-10-247","article-title":"Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma","volume":"10","author":"Rutella","year":"2012","journal-title":"J Transl Med"},{"issue":"12","key":"20","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1182\/blood-2006-03-009233","article-title":"Clinical implications of FLT3 mutations in pediatric AML","volume":"108","author":"Radich","year":"2006","journal-title":"Blood"},{"issue":"11","key":"21","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Anderson","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"22","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm.2819","article-title":"Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia","volume":"18","author":"Vande Woude","year":"2012","journal-title":"Nat Med"},{"issue":"7","key":"23","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.4049\/jimmunol.1201449","article-title":"Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer","volume":"190","author":"Ren","year":"2013","journal-title":"J Immunol"},{"issue":"15S","key":"24","first-page":"3004A","article-title":"Overcoming tumor antigen anergy in human malignancies using the novel indoleamine 2,3-dioxygenase (IDO) enzyme inhibitor, 1-methyl-D-tryptophan (1MT)","volume":"27","author":"Link","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nm1196","article-title":"Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy","volume":"11","author":"Prendergast","year":"2005","journal-title":"Nat Med"},{"issue":"4","key":"26","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0021-9258(19)77982-4","article-title":"Mechanism of interferon-\u03b3 action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-\u03b3 and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity","volume":"263","author":"Kido","year":"1988","journal-title":"J Biol Chem"},{"issue":"9","key":"27","doi-asserted-by":"crossref","first-page":"10132","DOI":"10.3390\/molecules180910132","article-title":"Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells","volume":"18","author":"Rutella","year":"2013","journal-title":"Molecules"},{"issue":"9","key":"28","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nri1435","article-title":"Tolerance, not immunity, crucially depends on IL-2","volume":"4","author":"Bayer","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"19","key":"29","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1182\/blood-2011-07-365817","article-title":"Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?","volume":"118","author":"Blazar","year":"2011","journal-title":"Blood"},{"issue":"1","key":"30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood-2005-08-027979","article-title":"Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction","volume":"109","author":"Costello","year":"2007","journal-title":"Blood"},{"issue":"2","key":"31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/sj.leu.2404485","article-title":"Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase","volume":"21","author":"Lemoli","year":"2007","journal-title":"Leukemia"},{"issue":"12","key":"32","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3324\/haematol.2010.025924","article-title":"Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells","volume":"95","author":"Lemoli","year":"2010","journal-title":"Haematologica"},{"issue":"1","key":"33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12032-010-9459-6","article-title":"Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells","volume":"28","author":"Abu-Zahra","year":"2011","journal-title":"Med Oncol"},{"issue":"12","key":"34","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.3324\/haematol.13112","article-title":"High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome","volume":"93","author":"Ossenkoppele","year":"2008","journal-title":"Haematologica"},{"issue":"200","key":"35","first-page":"200ra116","article-title":"Up-regulation of PD-L1, IDO, and Tregs in the melanoma tumor microenvironment is driven by CD8+ T Cells","volume":"5","author":"Gajewski","year":"2013","journal-title":"Sci Transl Med"},{"issue":"6754","key":"36","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Lanzavecchia","year":"1999","journal-title":"Nature"},{"key":"37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.it.2012.10.001","article-title":"Indoleamine 2,3 dioxygenase and metabolic control of immune responses","volume":"34","author":"Mellor","year":"2013","journal-title":"Trends Immunol"},{"issue":"2","key":"38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1182\/blood-2013-03-491621","article-title":"Results of the AIEOP AML 2002\/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia","volume":"122","author":"Rutella","year":"2013","journal-title":"Blood"},{"issue":"2","key":"39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/leu.2009.250","article-title":"Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia","volume":"24","author":"Rondelli","year":"2010","journal-title":"Leukemia"},{"issue":"1","key":"40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1182\/blood-2005-08-3141","article-title":"Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low\/neg accessory cells with dendritic-cell features","volume":"108","author":"Pierelli","year":"2006","journal-title":"Blood"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.1504","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T22:10:25Z","timestamp":1653171025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.1504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,30]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,4,30]]}},"alternative-id":["1504","24903009"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.1504","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,30]]}}}